The article analyzes the results obtained by a regular survey of Russian enterprises in the real sector conducted by the Institute of Economic Forecasting, Russian Academy of Sciences. The consequences of economic sanctions against Russia for enterprises are assessed. The views of enterprises on the desirable measures of anticrisis policy aimed at countering sanctions are outlined. Methods for adaptation to sanctions that are applied by the enterprises themselves are described. The opinion expressed by enterprises about the role of the state in the economy is presented. The situation with the investment activity of enterprises is considered. Data on the purchases of Russian and foreign equipment are given, as well as comparative assessments of the quality of this equipment. The views of Russian enterprises on the relevance of the climate agenda are presented, as well as their attitude to the ESG principles. The share of Russian enterprises that publish financial statements on risks associated with climate change as well as nonfinancial statements in the field of sustainable development is estimated. The proportion of enterprises that set themselves the goal of reducing their carbon footprint is revealed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707249 | PMC |
http://dx.doi.org/10.1134/S1075700722060089 | DOI Listing |
Nanomaterials (Basel)
January 2025
Enikolopov Institute of Synthetic Polymer Materials Russian Academy of Sciences (ISPM RAS), Profsoyuznaya St. 70, 117393 Moscow, Russia.
The results of a comprehensive investigation into the structure and properties of nanodiamond soot (NDS), obtained from the detonation of various explosive precursors (trinitrotoluene, a trinitrotoluene/hexogen mixture, and tetryl), are presented. The colloidal behavior of the NDS particles in different liquid media was studied. The results of the scanning electron microscopy, dynamic light scattering, zeta potential measurements, and laser diffraction analysis suggested a similarity in the morphology of the NDS particle aggregates and agglomerates.
View Article and Find Full Text PDFBiomedicines
December 2024
Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.
: About half of adults with acute myeloid leukemia with normal cytogenetics (CN-AML) have mutations. There is controversy regarding their prognosis and best therapy. : We studied 150 subjects with these features using targeted regional sequencing.
View Article and Find Full Text PDFClin Lymphoma Myeloma Leuk
December 2024
Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
BCR::ABL1-negative myelo-proliferative neoplasms (MPNs) are characterized by mutations in JAK2, CALR, or MPL. Usually these mutations are co-exclusive of each other and of BCR::ABL1. We reviewed clonal interactions in 177 subjects with mutations in JAK2, CALR, or MPL and BCR::ABL1 including JAK2/BCR::ABL1 (N = 142), CALR/BCR::ABL1 (N = 31), MPL/BCR::ABL1 (N = 3).
View Article and Find Full Text PDFExpert Opin Ther Pat
January 2025
P. Hertsen Moscow Oncology Research Institute, Moscow, Russian Federation.
Introduction: The ataxia telangiectasia mutated kinase (ATM) is key in coordinating the DDR signaling network essential for responding to double-strand breaks (DSBs). Several ATM inhibitors are being investigated for potential anticancer treatment in clinical trials.
Areas Covered: This review aims to provide a comprehensive overview of patents and patent applications since 2003, with a particular focus on the structural properties, activity and efficacy of the claimed ATM kinase small-molecule inhibitors.
Blood Rev
December 2024
Centre for Haematology, Imperial College of Science, Technology and Medicine, London, UK; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Chemo- and immune therapies administered to treat haematologic malignancies frequently cause neurologic injury. The adverse events range from mild cognitive impairment and headaches to severe conditions such as seizures, stroke and encephalitis. We performed a comprehensive literature review and report the types, mechanisms, management and prevention of neuro-toxicity resulting from these therapies in subjects who develop these toxic effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!